Association of Finerenone Use With Reduction in Treatment-Emergent Pneumonia and COVID-19 Adverse Events in Patients With Type 2 Diabetes and Chronic Kidney Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Network Open
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Association of Finerenone Use With Reduction in Treatment-Emergent Pneumonia and COVID-19 Adverse Events Among Patients With Type 2 Diabetes and Chronic Kidney Disease: A FIDELITY Pooled Secondary Analysis
JAMA Netw Open 2022 Oct 26;5(10)e2236123, B Pitt, R Agarwal, SD Anker, LM Ruilope, P Rossing, C Ahlers, M Brinker, A Joseph, M Lambelet, R Lawatscheck, GS FilippatosFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.